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Perhaps no
issue excites as much angst among
members of the medical staff than that
of the medical manpower plan. A
detailed discussion of this issue took
place at the .Medical
Staff/Administrative Exchange
Session on Thursday, June 15, 1995.
Here are some of the highlights.
The medical manpower plan was
developed initially in 1982 to identify
those specialties and sub-specialties
faced with inadequate supply of
physicians, or in which a supply of
physicians was likely to exceed the
resources available within the hospital.
Input was solicited from 36
Division/Section meetings. The result
was an adjustment driven plan in 1982
which had many problems. By
September of 1986, the plan was
developed to include a semi-annual
needs survey where physicians could
IIsem1-annua
•
llyII s ubm1't thetr
• requests
for additional manpower through a
formal process. Specification
statements, including the two-year
rule, capitations, stipulations and
compatibility statements, were made at
that time. "Brainstorming" groups
which incl~ded all the Chairpersons,
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the CEO, Medical Staff President, the
Senior Vice President for Medical and
Academic Affairs, the Senior Vice
President of Lehigh Valley Health
Services Division, and the Vice
President for Medical Staff Services
met to review and discuss these needs
which were then debated by the
Medical Executive Committee who
remained involved in the review and
approval process. The Board of
Trustees had the final action in all
requests at that time as it does now.
In 1993, the Med Exec created a
separate body to consider manpower
needs and removed itself from the
process of slot approvals, denials and
revisions. This was done after a
prolonged and thorough discussion by
members of the Medical Executive
Committee who concluded they had an
ethical obligation to refer this material
to a separate board due to increasing
conflict of interest which tainted them
from making unbiased decisions. A
new process of assessing staff
development was created by instituting
a formal poll of the medical staff which
requests their objective assessment of
manpower needs. In this survey, every
member of every division has the
opportunity to comment on whether

(Continued on Page 2)
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they feel that their neighboring
divisions and departments are meeting
their needs in the care of patients.
This single summary source of the
medical staff proves to be the most
objective and important document in
the assessment of manpower needs.
Currently, members of the medical
staff may submit their request for
increased manpower semi-annually
during the time periods from August
15 through September 14, and again
from February 15 through March 14.
Department Chairpersons solicit input
and formal recommendation from the
Division/Section Chiefs and carry
those recommendations to the
monthly meeting of the TROIKA/
Chairpersons Committee, which
consists of 12 department
Chairpersons, the CEO, the COO,
the Senior Vice President of Clinical
Services, the Vice President for
Medical Staff Services, the Medical
Staff President, Past President of the
Medical Staff, and the Medical Staff
President-Elect. Recommendations
from the Combined TROIKA/
Chairpersons Committee are presented
to the Performance Improvement/
Staff Development Committee of the
Board of Trustees, which then submits
the final recommendation to the
Board of Trustees. A report from the
Combined TROIKA/Chairpersons
Committee is given to Med Exec for
information purposes only. The Board
of Trustees ultimately makes the final
decision on the request for that
additional medical manpower based on
recommendations forwarded to them
by these groups.

Currently, the Hospital Staff
Development Plan retains "a two-year
rule" given to physicians who are
(·
voluntarily terminated from practice
prior to a two year date. It reads as
follows:
"Immediately upon the receipt of
notification from a private practice
group that an individual has been
involuntarily terminated from his
group, or when an individual is no
longer employed under a contract with
the hospital, the individual would lose
medical staff privileges and
membership. These individuals would,
however, be permitted to request a slot
within 60 days of such notification
requiring immediate consideration by
the TROIKA/Chairpersons
Committee, the Staff Development
Committee of the Board of Trustees,
and the Board of Trustees at their next
scheduled meeting. Voluntary
(
termination from either private
practice group or hospital contracts
will be reviewed only during the normal
semi-annual needs survey cycle."
There remains some common
misconceptions of the Hospital Staff
Development Plan which I thought
would be worth restating here:

e Slots are automatically granted
when an individual leaves the group or
retires.
This statement is false. Even when a
senior member of a group retires, that
slot is not automatically granted to the
group and needs to be requested and
moved through the process from
(Continued on Page 3)
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Division to Department Chairperson
to the Board. While it is usually the
case that replacement slots are granted,
it is not automatic and in some
instances planned attrition of divisions
would require that replacement slots
not be filled.

e

Division/Section should vote on slot
requests.
The plan mandates Division/Section
Chiefs give a formal recommendation
and it is encouraged that discussion of
manpower needs in general take place
at Division/Section meetings.
However, votes on individual slot
requests in these meetings should be
avoided as they are a violation of
federal anti-trust laws. This prevents
small divisions with perhaps a single
group from unfairly stamping out
competition by preventing new
members to join their group, even
when it is felt it is needed by the
manpower survey and the
TROIKNChairpersons Committee to
meet patient care needs.
• Division/Section Chief
recommendations are automatically
approved by the Chairperson, the
TROIKNChairperson Committee and
the Board of Trustees.
The Division/Section Chiefs
recommendations are taken very
seriously and carry a great deal of
.
weight. They are also weighed with the
individual need of a particular group,
particularly a group that has provided
loyal service to this hospital and its
patients or has been intimately
involved in the teaching program.

e

Hospital slots are equivalent to
Lehigh Valley Physician Group
employed physicians.
Often Chairpersons will identify
"hospital slots" and these are mistaken
as slots for members employed by the
Lehigh Valley Physician Group. The
term "hospital slot" simply means it is
a generic slot which can be filled by
any member of the division or LVPG,
and is not given to one specific group.
For example, if the need for a pediatric
surgeon was identified as a hospital
slot, that slot could be filled by any
member of the private practice groups
or by LVPG during the search process.

e Approved slots are good for two
years.
Slots are approved for a period of one
year and an opportunity exists to make
a request to have the slot renewed for
an additional second year. This
approval is by no means automatic and
all requests for renewal will be
considered in the same manner as
original slot requests. An excerpt from
the plan follows, which deals with the
Board of Trustee's right to eliminate
existing slots:
"While the Board recognizes its
ultimate right to consider the
appropriate number of medical
specialists and sub-specialists to
provide optimal care to patients the
hospital serves, it envisions that this
will be regulated through access to the
medical staff via the staff development
plan process rather than retrospective
elimination of slots. However, because
(Continued on Page 4)
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of constant and frequent changes in
health care delivery system, it may be
counter productive to the hospital's
well being to continue certain existing
vacant unfilled slots. Therefore, the
Board of Trustees reserves the right to
eliminate already approved slots."

e

Slots can be requested at any time.

Slots for a group can only be requested
during the semi-annual needs survey,
during the time periods from August
15 through September 14, and again
from February 15 through March 14.
Hence, this requires some planning by
everyone on the medical staff.

e

Slot requests are necessary for active
staff only.
This is not true. Slot apP.rovals are
required for all active staH and
currently courtesy staff in the
Department of Surgery. The Plan has
been amended from time to time to
permit inclusion of staff categories
other than active to be included in the
approval process of the plan.

e

The dissolution of a group entitles
the resulting separate entities to new or
existing open slots.
This issue is obviously complex and
one which again is poorly understood.
It evokes the two-year rule for
members that leave \'rior to two years
with a grouJ?, hence losing their slot,
and those that have been with a group
over two years to carry their slot with
them. Other than that, existing open
slots are not carried away from the
original group from which they have
been awarded.

The July 20, 1995 Medical
.,
Staff/Administrative Exchange
Session was dedicated to the discussic(
of the Lehigh Valley ~hysician Group
which employs the full-time physicians
here at the hospital. The results of
that discussion will be shared in a
future issue of Medical Staff Progress

Notes.
The re-design of the medica1!surgical
floors under the concept of "patient
centered care" is \'rogressing at the
expected pace with 7A being complete
and 7B and 7C almost complete at
this time. The nurses on 6B and
medical directors of that floor have
been involved with planning the future
of that endeavor as well. We
appreciate many of your helJ?ful
comments, and anticipate that each
time we build a new floor we will
incotporate these suggestions into the
new Hoar and again improve on it.
One clear cut improvement which is (
necessary is additional writing space
for physicians. On 7A, 7B and 7C,
we will move the computers off the
writing space that is P.rovided for the
physicians and we will also provide
foldout writing carousels at each of the
doors to hold the charts. We
anticipate that these carousels will have
the ability to be "flagged" when orders
on charts are written. Please don't
hesitate to forward your suggestions to
me in order to make these areas as
useful to physicians and nurses as
possible.
I hope you all are enjoying the
beautiful summer weather.

~~~~
John E. Castaldo, M.D.
President, Medical Staff
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Director o/ Emergency Services Named
Elizabeth Brennan, RN, EdD,
CCRN, has been named Director of
Emergency Services and MedEvac.

Philadelphia. She has done extensive
consulting in facility and systems
redesign related to emergency services.

In her new position, Dr. Brennan will
be responsible for the Emergency
Department at both Cedar Crest & 178 and 17th & Chew and the
MedEvac team.

Dr. Brennan received her nursing
degree from Delaware County
Community College and a doctorate in
Health Education from Temple
University.

Previously, Dr. Brennan was manager
of the Emergency Department at
Albert Einstein Medical Center in

New Telephone
Numbers /or Patient
Centered Care Units
Patient related phone calls should be
directed to the Patient Team area
phone extension identified below which
corresponds to the patient's room
nwnber:
7B
Team Area 1 - Rooms 1-5 - #8761
Team Area 2- Rooms 6-10- #8792
Team Area 3- Rooms 11-14- #8793
Team Area 4- Rooms 15-18- #8794
The phone extension for calls not
related to a specific patient is 8795.
7C
Team Area 1 -Rooms 1-5- #1981
Team Area 2- Rooms 7-10- #1982
Team Area 3- Rooms 11-15-#1983
Team Area 4- Roomsl6-19- #1974
The phone extension for calls not
related to a specific patient is 8755.

REMINDER

When a patient exPires, it is
the responsibility of the
family/significant other to
contact the funeral director. If
a patient does not have any
family/significant other, contact
the Social Service Department
for assistance.
It is extremely important that
this be communicated during
your interactions with the
family/significant other of the
deceased patient as they may
otherwise assume that the
hospital will contact the funeral
director.

PageS

L VDI Diagnostic Results Now Available through

PHAMIS
Effective ]Wle 28, Lehigh Valley
Diagnostic Imaging {LVD I) began
using PHAMIS for their diagnostic
reporting. You may now access LVDI
results via Ancillary Transcription
Review within the MPI command.
This implementation includes all
outpatient studies and Cedar Crest
inpatient mammographies.

However, as orders may not be placed
on PHAMIS for LVDI, please
continue to call LVDI at 435-1600
for an appointment. LVDI will enter
the necessary information for you. In
addition, LVDI will continue to
perform procedures on a walk-in basis
as well.

Admitting Protocol Changes at 17th & Chew
Effective July 2, responsibility for
admitting patients was shifted to the
Emergency Department Registrar
beginning at 8:30p.m., Monday
through Friday, noon on Saturday,
and all day on Sunday. This change
allows for enhanced service to patients
during peak volume times. The
Emergency Department Registrar is

located on the ground floor at 17th &
Chew, just off the Emergency
Department waiting area.
However, please continue to call402·1
2217 during these times to contact an
Admitting registrar regarding
admissions or any other admitting
related questions.

Helwig Diabetes Center Receives State Recognition
The Helwig Diabetes Center staff
recently received notification from the
Pennsylvania Department of Health
that their outpatient diabetes
education program meets national
standards for diabetes patient
education.
Recognition is a volm1tary but formal
process of identifying hospital-based
diabetes outpatient education
programs in Pennsylvania that meet

national standards. Recognition
provides continuing assurance that an
education program merits the
confidence of the commWlity it serves.
For more information about services
provided by the Helwig Diabetes
Center, please contact Kim Sterk,
Nurse Coordinator, at 402-9885.
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Guidance Program Opens Bethlehem Office
Lehigh Valley Hospital's outpatient
mental health service, the Guidance
Program, recently opened an office in
northern Bethlehem to serve persons
in eastern Lehigh, Northampton, and
Monroe counties.
The office is located at 3005
Brodhead Road, Suite 20, where
therapists will provide marriage and
family therapy, conduct art and play
therapy with children, and treat
adolescents and adults for depression,
anxiety, and mood disorders.
Appointments are available Monday
through Friday, afternoons and
evenings. Psychiatric evaluations and
medication monitoring will continue

to be performed at the Guidance
Program's main office at 1255 S.
Cedar Crest Blvd., Suite 3800,
Allentown.
The Guidance Program opened in
1993 to provide short-term mental
health services to children, adolescents,
adults, and families. Patients are
treated for depression, anxiety, marital
and interpersonal problems,
psychosomatic disorders, hyperactivity,
school difficulties, and the effects of
trauma and abuse.
For more information or to make an
appointment, please call the Guidance
Program at (610) 402-5900.

News /rom Research

Call for Abstracts

Research Advisory Committee
- Request for Proposals

A call for abstracts has been issued by
the following:

The Research Advisory Committee
(RAC) meets bi-monthly to review
clinica]fepidemiological research
proposals (requests for funding)
submitted by the Medical and
Professional staff of Lehigh Valley
Hospital. All proposals must be
submitted to the Research Department
for review three weeks before the next
scheduled RAC meeting. The next
meeting of the RAC is Thursday,
August 17.
For more information or proposal
guidelines, please contact James F.
Reed III, PhD, Director of Research,
at 402-8889.

rr The American College of Cardiology for the
45th Annual Scientific Session to k held on
March 24, 1996 in Orlando, Fla.
Submission due date is Septemkr 8, 1995.
rr The Institute of Applied Physiology
Medicine for the 1996 Cerebral
Hemodynamics Symposium to k held on
January 22, 1996 in Dallas, Texas.
Submi81ion due date is Septemkr 8, 1995.
rr The Society of Critical Care Medicine for
the 1996 Annual Meeting to k held on
February 5, 1996. Submission due date is
Septemher 1, 1995.

For inst~ctions, forms, and further
information, contact Kathleen Moser
in the Research Department at

402-8747.
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Congratulations!
George F. Carr, DMD,
prosthodontist and Vice Chairperson,
Department of Dentistry, was elected
President of the Pennsylvania
Prosthodontic Association at its
annual meeting held in June in State
College, Pa.
Pragnesh A. Desai, DO, urologist,
was recently notified by the American
Osteopathic Board of Surgery that he
successfully completed and passed the
required examinations for certification
in Urological Surgery.

Richard M. Hennan, MD,
otolaryngologist, recently received
notification of his certification as a
Diplomate of the American Board of
Otolaryngology.
Ronald A. Kri1ch, MD, psychiatrist,
was recently elected to Fellowship in
the American Psychiatric Association.
Catharine L. Shaner, MD,
pediatrician, was recently notified by
the American Board of Pediatrics that
she has met the requirements for
renewal of certification in the specialty
of general pediatrics.

Papers, Publications and Presentations
National Emergency Medical Services
Week was celebrated at Lehigh Valley
Hospital with a lecture series and light
dinner for over 150 EMTs and
paramedics on May 12. Hospital staff
members who served on the faculty
included Rohert 0. Atlas, MD,
Department of Obstetrics and
Gynecology; and Jerome C. Deutsch,
DO, and John F. McCarthy, DO,
Department of Emergency Medicine.
Alexander M. Rosenau, DO, also
from the Department of Emergency
Medicine, was the moderator for the
evening.
"Endarterectomy for Asymptomatic
Carotid Artery Stenosis," a reporl
detailing the Asymptomatic Carotid
Atherosclerosis Study in which Lehigh
Valley Hospital was a participant, was
published in the May 10, 1995 issue

of].AMA. John E. Castaldo, MD,
Medical Staff President, neurologist,
and a member of the Executive
Committee for the Asymptomatic
Carotid Atherosclerosis Study, was one
of the co-authors of the report.
Jay S. Cowen, MD, Division of
Pulmonary Medicine, was one of the
co-authors of an article, "Recognition,
Assessment, and Treatment of Anxiety
in the Critical Care Patient," which
appeared in the May, 1995 issue of
Disease-a-Mont/.. In addition, Dr.
Cowen was among the writing panel
who developed the Guidelines for
Resident Training in Critical Care
Medicine which were approved by the
governing Council of the Society of
Critical Care Medicine.
(Continued on Page 9)
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Thoma• B. Dickson, MD,
orthopedic surgeon, attended the 18th
National Conference and Exhibition
of the National Strength and
Conditioning Association from Jnne
21 to 24. At the conference, held in
Phoenix, Ariz., Dr. Dickson gave the
keynote address and a presentation on
"Drug Use and Testing in Athletics."
"Preparing For and Managing the
Podiatric Office Emergency," written
by Marna R. Greenberg, DO,
Department of Emergency Medicine,
was published in the Jnne 1995 edition
of The Lower Extremity.
Peter A. Kehlish, MD, chief of the
Division of Orthopedic Surgery, was
an invited guest and keynote speaker
on knee replacement at the Societe
D'orthopedie-Trawnatologie de l'est de
la France (SOTES1) in Metz,
France. Dr. Keblish addressed the
topic of the basis for total knee
replacement in surgery of the knee.
SOTEST is one of two major
orthopedic societies in France with
attendance of over 300 orthopedic
surgeons from the region. Dr. Keblish
also participated in group discussions
on various aspects of total joint
arthroplasty.
lndru T. Khuhchandani, MD,
colon-rectal surgeon, was invited to
give a named oration at the Fifth
Asian Congress of Coloproctology at
Seoul, Korea, on Jnne 1 to 4. The
title of the presentation was
"Coloproctology -- Has Cinderella
finally met her Prince Charming?" He
also spoke about "Complex Fistula in
Ano" at another session. The meeting
was attended by 1,299 registrants,

largely from the East Asian/Pacific
basin conntries.
Le1ter Ro1en, MD, Program
Dii·ector, Colon/Rectal Surgery
Residency, participated in the
American College of Surgeons (ACS)
Advisory Connell meeting in Chicago,
Ill., on Jnne 7. The ACS Advisory
Conncil consists of representatives of
each of the surgical specialties. The
purpose of the meeting was to gather
consensus of reporting of surgical
outcomes. Dr. Rosen was invited to
this meeting as a consultant to discuss
how Mediqual software, which is
legislated for use in Pennsylvania, can
be used to study outcomes.
A joint hospital- extended care facility
- paramedic ronndtable conference was
held at Lehigh Valley Hospital on May
9. Alexander M. Rosenau, DO,
Department of Emergency Medicine,
lectured and moderated the panel
discussion as participants identified
problems and proposed solutions
concerning the interfacing of these
three types of caregivers.
Joseph E. Vincent, MD, chief,
Division of Pulmonary Medicine, and
Stephen E. Larnrner1, Ethics
Consultant, co-authored Chapter 58 -Ethics and Patient Care of
Comprehensive Respiratory Care.
Steven L. Zelenkofske, DO,
cardiologist, was recently informed
that his abstract, ''The Effect of Rate
Modifying Agents on the P-Wave
Signal Average Electrocardiogram,"
has been accepted for oral presentation
at the lOth World Symposiwn on
Cardiac Pacing and Electrophysiology
to be held in Buenos Aires, Argentina
from October 22 to 26.
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Health Promotion and Disease Prevention News
(

Camp HealthRock
This summer, Lehigh Valley Hospital
provides the perfect antidote for the
summertime blues: CamJ?
HealthRock, a cool, five-day adventure
exclusively for children. There will be
plenty for kids to yabba-dabba-do
including activities that will mix fun
with learning in the areas of fitness,
nutrition, and safety, among others.
Call today to find out how you can
helJ? your children improve their
health, take on new challenges and
responsibilities, and have a lot of fun
in the process. All educational
materials, daily lunches and snacks at
the HealthRock Cafe, along with a
Camp HealthRock tee-shirt, are
included in the program fee.
Registration is limited to 30 children
per weekly session.
Remaining sessions will be held from
July 31 through August 4 (ages 10 to
12) and August 21 through 25 (ages 7
to 9). Daily camp sessions are held
from 8:30 a.m. to 4:30 p.m., with
drop-off beginning at 7:30a.m., and
pick-up until5:15 p.m. All sessions
are located at Lehigh Valley Hospital
Wellness Center on Fish Hatchery
Road.
For more information or to register,
call Health Promotion and Disease
Prevention at 402-5960.

Stand Up to Osteoporosis
Osteoporosis, which affects over 25
million Americans, is also known as
''The Silent Thief," because it
progresses without any symptoms or
pain. But through minor lifestyle

changes including a healthier diet and
regular, weight-bearing exercise,
individuals can dramatically reduce
their chances of developing the disease.
A two-part program regarding
Osteoporosis and steps to combat this
disease will be held on August 9 and
16, from 1:30 to 3 p.m., at 1243 S.
Cedar Crest Blvd., Lower Level. For
more information or to register, call
402-5960.

Sm.oking Cessation Hypnosis
A one-time, hour-long, inexpensive
program ideal for those q:uitting for
either the first time or after many
tries. Led by a certified hypnotherapist
and psychologist, this program may be
used in conjunction with other
smoking cessation programs to
increase the participant's ability to
quit.
Sessions will be held on Tuesday, July
25, from 7 to 8 p.m., and Friday,
August 11, from 3 to 4 p.m., both in
Classroom 3 of Lehigh Valley
Hospital, Cedar Crest & I-78.
For fees or additional information, call
402-5960.

• ••••
These and many other programs for
nutrition and weight control, stress
management, fitness, and nicotine
dependence services are available
through the Health Promotion and
Disease Prevention Department.
For more information on any of these
programs, call402-5960.
Page 10

Upcoming Seminars,
Conferences and
Meetings
Medical Staff/Administrative
Exchange Session
The August Medical Staff/
Administrative Exchange Session
will be held on Thursday, August 17,
beginning at 5:30p.m., in Conference
Room 1, Side B, of the John and
Dorothy Morgan Cancer Center.
It is of paramount importance that as
many physicians as possible attend
these sessions to participate in the
exchange of information about
important topics in a timely manner.
Topics to be discussed will be posted
throughout the hospital prior to the
session.
For more information, contact John

E. Castaldo, MD, Medical Staff
President, through Physician
Relations at 402-9853.

Hill Burton Program
Hill Burton funding is available
to qualifying indigent patients
who require hospital-based
services provided by Lehigh
Valley Hospital. Services such
as those provided by Lehigh
Magnetic Imaging Center,
Lehigh Valley Diagnostic
Imaging, Affinity, and others
which are not hospital-based,
are NOT included inthe Hill
Burton Program. Patients who
require but are unable to pay
for these services should deal
directly with these ancillary
departments.
If you have questions
regarding this issue, contact
Sandra Colon, Director of
Finance/Patient Accounting, at
402-9461.

Psychiatry Grand Rounds
Borderline Personality Disorder
will be presented" by Suzanne Lego,
RN, PhD, CS, FAAN, private
practitioner in Pittsburgh, Pa., and
Kent, Ohio, on Thursday, August 17,
beginning at noon in the Auditorium
at 17th & Chew.

As lunch will be provided, preregistration is requested. For more
information or to register, contact Lisa
Frick in the Department of Psychiatry
at 402-2810.
Page 11

"Who's New

Masayuki Kazahaya, MD

update of new appointments, address
changes, newly approved privileges, etc.
Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

(Drs. Buchanan and Oliver)
Fairgrounds Medical Center
400 N. 17th Street, #200
Allentown, PA 18104-5052
(610) 433-2021
FAX: (610) 433-7856
Department of Surgery
Division of Ophthalmology
Provisional Active

Medical Staff

Steven}. Perch, MD

The Who's New section of Medica/
Staff Progress Notes contains an

Appointments

Eugene Alexandrin, MD
Lehigh Valley Pathology Associates
(Dr. Shane)
Cedar Crest & I-78
P.O. Box689
Allentown, PA 18105-1556
(610) 402-8152
Department of Pathology
Division of Clinical and Anatomic
Pathology
Provisional Active

Douglas K. Atno, DMD
{solo)
581 Main Street
P.O. Box 215
Pennsburg, PA 18073-0215
(215) 679-9675
Department of Dentistry
Division of General Dentistry
Provisional Active

Jon E. Brndjar, DO
Lehigh Valley Physician Group
Lehigh Valley Hospital
Cedar Crest & 1-78
Allentown, PA 18105-1556
(610) 402-1150
FAX: (610) 402-1675
Department of Medicine
Division of General Internal Medicine
Provisional Active

Allentown Radiation Oncology
Associates
(Dr. Risch)
John & Dorothy Morgan Cancer
Center
Cedar Crest & I-78
Allentown, PA 18105-1556
(610) 402-0700
FAX: (610) 402-0708
Department of Radiation Oncology
Provisional Active

Neal A. Stans.bury, MD
Valley Sports & Arthritis Surgeons
(Dr. Sussman)
1230 S. Cedar Crest Blvd.
Suite 101
Allentown, PA 18103-6237
(610) 820-5200
FAX: (610) 820-0359
Department of Surgery
Division of Orthopedic Surgery
Provisional Active
Fa-r L. Stricklin, DMD
(solo)
31 S. 17th Street
Easton, PA 18042-3980
(610) 252-0646
Department of Dentistry
Division of General Dentistry
Provisional Active
(Continued on Page 13)
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Prodrornos A. Ververeli, MD
Valley Sports & Arlhriti~ Surgeons
(Dr. Sussman)
1230 S. Cedar Crest Blvd.
Suite 101
Allentown, PA 18103-6237
(610) 820-5200
FAX: (610) 820-0359
Department of Surgery
Division of Orthopedic Surgery
Provisional Active
James C. Weis, MD
Orthopaedic Associates of Allentown
(Dr. Keblish)
1243 S. Cedar Crest Blvd.
Suite 2500
Allentown, PA 18103-7982
(610) 433-6045
FAX: (610) 433-3605
Department of Surgery
Division of Orthopedic Surgery
Provisional Active

Additional Privileges
Kenneth P. Skorinko, MD
Department of Medicine
Division of Cardiology
Direct Coronary Atherectomy
Privileges

Address Changes
Mishkin Rappaport Shore Rentler
Internal Medicine
Mark H. Mishkin, MD (Effective
August 4, 1995)
Russell J. Rentler, MD (Effective
August 21, 1995)
Stephen R. Shore, MD (Effective
August 4, 1995)
1251 S. Cedar Crest Blvd.
Suite 112
Allenlown, PA 18103-6244

Brian L. Fellechner, DO
Good Shepherd Rehab Hospital
501 St. John Street
Allentown, PA 18103-3296
(610) 776-3278
FAX: (610) 776-3172

Telephone Number Change
Yasin N. Khan, MD
Lehigh Valley Pain Management
(610) 366-9000
FAX: (610) 366-9229

Leave of Absence - Additional
Year
Harry W. Stephens, MD
Department of Surgery
Division of Neurological Surgery
Emeritus Active/LOA

Resignation
Ralph H. Scott, MD
Department of Pathology
Division of Clinical and Anatomic
Pathology

Allied Health Professionals
Additional Privileges
Diana A. Searfoss
Physician Extender
Technical
(Dr. Buchanan)

Change of Supervising
Physician
Sandra J. Vitello, PNP
Physician Extender
Professional - PNP
(Hospital)

Change from Charles F. Smith, MD
to Robert W. Miller, MD
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P & T HIGHLIGHTS
The following actions were taken at the June 21, 1995 Pharmacy
and Therapeutics Committee Meeting- Maria Barr, Pharm.D.,
Barbara Leri, Pharm.D.

H2 ANTAGONIST 48 HOUR STOP
Overuse of H2 antagonists is well
documented in the literature.
The
conunittee discussed the current use at LVH
and raised many concerns. The potential
side effects including CNS and hematologic
abnormalities appear to out weigh the
benefits of routine use in hospitalized
patients. One service has already addressed
this issue. The trauma service stress ulcer
prophylaxis protocol reserves H2 antagonist
therapy for patients at high risk only and
utilizes sucralfate first line therapy. This
protocol realized an annualized savings of
approximately $10,000.
In an effort to eliminate unnecessary and
prolonged therapy with H2 antagonists for
stress ulcer prophylaxis, a 48 hour
automatic stop has been approved and will
begin July 24, 1995. Physicians MUST
reorder
H 2 antagonist therapy for
continuation.

GLUCOPHAGE ... THE
SUCCESSOR OF PHENFORMIN
IS HERE AT LVH
A recently approved agent, Glucophage
(MetforminR, Bristol-Myers Squibb), has
been approved for addition to the formulary.
It is a non-sulfonylurea which may be used
alone as an adjunct to diet or in combination

with a sulfonylurea which is not adequately
controlling blood sugars in NIDDM.
Glucophage improves glucose tolerance in
NIDDM patients by lowering both the basal
and postprandial plasma glucose.
Glucophage works differently compared to
the sulfonylureas through a decrease in
hepatic glucose production, a decrease in
intestinal absorption of glucose and
improvement of insulin sensitivity.
Hypoglycemia does not result from,
glucophage therapy, adding to the advantage
of this agent.
Concerns related to the potential adverse
effects of glucophage, especially lactic
acidosis was addressed by endocrine. Lactic
acidosis, though rare, can occur secondarily
to accumulation of glucophage. When it
occurs, it is fatal in 50% of the cases.
Reported cases have occurred primarily in
diabetic patients with significant renal
insufficiency. The risk of lactic acidosis
increases with the degree of renal
dysfunction and the patient's age. Due to
impaired hepatic function, the body may not
be able to adequately clear lactate. Patients
should be cautioned against excessive
alcohol intake while receiving metformin
due to alcohol's ability to potentiate the
effect of glucophage on lactate metabolism.
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Glucophage is considered to be
contraindicated in patients with renal disease
or renal dysfunction, suggested by a serum
creatinine of 2.. 1.5mg/dl. The drug should
be temporarily withheld (at least 48 hours
prior to and 48 hours after procedure) in
patients undergoing radiologic studies
involving parenteral contrast dyes due to the
possibility of acute changes in renal
dysfunction with the use of these agents.
Finally, the drug should be withheld in
patients with any type of hypersensitivity to
metformin or have an underlying chronic
metabolic acidosis including diabetic
ketoacidosis with or without coma.
Many precautions exist for glucophage,
some of which include the monitoring of
renal function, concomitant use of other
medications which alter renal function,
hypoxic states, alcohol intake and impaired
hepatic function.
In addition to lactic acidosis, other potential
adverse effects include gastrointestinal
reactions,
alteration of taste and
asymptomatic subnormal vitamin B12 levels.
The usual starting dose for glucophage is
500mg PO BID administered with the
morning and evening meal with dosage
increments of one tablet every week to a
maximum of 2550mg/day.
The usual
maintenance dose is 850mg PO BID.
Monitoring of glycosolated hemoglobin
should occur approximately every three

months. Fasting plasma glucose should be
used to determine the therapeutic response
to glucophage.

(

The expected costs of this agent will range
from $0.70 to $1.95/day.
An educational chart memo is in
development to assist physicians with
monitoring and managing patients on
glucophage while hospitalized.

NO MORE PHONE CALLS....
EXPANSION OF THE
THERAPEUTIC SUBSTITUTION
LIST
By popular demand, we have revised the
therapeutic substitution list at L VH to
include frequently ordered non-formulary
medications.
Historically, a physician
would receive a phone call for every nonformulary medication ordered to change it to
an available formulary agent. A list was
developed of the most frequent nonformulary medications orders to eliminate
the need for phone calls. A therapeutic
substitution including dosages for the listed
agents will automatically occur with an
order change sent from pharmacy.
Physicians may continue patients personal
supply from home, with a written order
stating "patient may use own supply" next to
the medication order. The list of agents is
on the next page:
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DRUG DISPENSED

SUBSTITUTED FOR

lisinopril (Zestril, Prinivil)

benazepril (Lotensin)
quinapril (Accupril)

chewable ASA 81mg

enteric coated ASA 81mg

azithromycin (Zithromax)

clarithromycin (Biaxin)

enalapril (Vasotec)

ramipril (Altace) ·

lovastatin (Mevacor)

fluvastatin (Lescol)
pravastatin (Pravachol)

amlodipine (Norvasc)

felodipine (Plendil)
isradipine (Dynacirc)

metoprolol (Lopressor)

metoprolol XL (Toprol XL)

acetaminophen 650mg and
propoxyphene 1OOmg (Darvocet N 100)

tramadol (Ultram)

cefuroxime axetil (Ceftin)

cefaclor (Ceclor) capsules

oxycodene 5mg and APAP 325mg
(Percocet)

- hydrocodone bitartrate 5mg
and APAP 500mg (Vicodin)
- hydrocodone bitartrate 7. 5mg
and APAP 750mg (Vicodin ES)

calcium carbonate (Titralac)

calcium carbonate (Turns)

cholestyramine powder (Questran)

colestipol granules (Celestid)

cephlalexin (Keflex)

cefadroxil (Duricet)

isosorbide mononitrate (lsmo)

isosorbide mononitrate (lmdur)

guaifenesin (Robitussin plain)

guaifenesin LA (Humibid LA)

nitrofurantoin (Macrodantin)

nitrofurantoin SR (Macrobid)

glipizide (Glucotrol)

glipizide XL (Glucotrol XL)
(QD orders only)
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A NEW TWIST FOR OLD
DRUGS..• AMINOGLYCOSIDES
EXTENDED- DOSING INTERVAL
Many institutions have adopted an extendedinterval dosing regimen for
aminoglycosides.
The relatively n~vel
approach to administering aminoglyc~stdes
is based on two important properties of
these drugs. First, aminoglycosides have
concentration-dependent activity.
The
higher the concentration, the better killing
activity of the aminoglycosides. Secondly,
aminoglycosides possess a "post-antibiotic"
effect. Even though there may be an
undetectable amount of aminoglycoside in
the patients system, suppression of the
bacteria can still be achieved.
The dosing of either gentamicin or
tobramycin would be achieved through using
5mg/kg (based on ideal body weight)
administered once daily in patients with
nonnal renal function i.e. estimated CrCI
> 50mllmin. The dosing interval would be
extended to Q36 hours for patients with
estimated CrCI between 30-49 ml/min and
Q48 hours for 20-29 ml/min, respectively.
Patients with CrCl < 20ml/min or with
ARF should receive a single dose of 2mg/kg
(IBW) and the dose should be adjusted based
on levels and dialysis schedule, if
applicable.
Monitoring of extended-interval
aminoglycosides is less complex than the
present recommendations. Renal function
needs to be assessed a minimum of Q3 days
while receiving aminoglycosides. Only a
random level 16-20 hours post-dose needs to
be assessed. The latter offers the advantage
of having the random level available prior to
the next dose. It would allow for extension
of the dosing interval, if necessary. The
random level should be < lmg/dl to

prevent accumulation of the drug. If the
random level is less than lmg/dl, DO NOT
shorten the dosing interval. This level is
meant to monitor for avoidance of toxicity
rather than interpretation for therapeutic
effect. The specific time of monitoring a
random level should be indicated on the
physicians order. Random levels between
16-20 hours after the dose can be checked
following the first dose and Q5-7 days,
thereafter, if necessary, assuming renal
function is stable.
More frequent
monitoring may be necessary for rapidly
changing renal function. Peak levels do not
need to be monitored utilizing the extendedThe high serum
interval dosing.
concentrations achieved by this dosing
regimen negate the need to check peak
concentrations for aminoglycosides.
Certain patients may not be candidates for
extended interval.
These populations
include:
- neutropenic patients (ANC < 1000)
- suspected or documented treatment of endocarditis
- patient with cystic fibrosis, cirrhosis, ascites or
myasthenia gravis
- pregnant patients or nursing mothers
- patients on dialysis or ARF patients
- patients treated for staphylococcal or enterococcal
infection when aminoglycosides are used for synergy
- patients with a h/o drug-induced ototoxicity
Dosing:
A.

Calculate Creatine Clearance
Males: (140-age) x IBW
Scr x 72

IBW

B.

Females: CrCI(males) x 0.85
= ideal body weight (See chart on next page)
Dose as follows

Est. CrCI
2!_ 50ml/min

30-49ml/min
20-29ml/min
< 20ml/min

Dose
5mg/kg/24 hrs
Smg/kg/36 hrs
Smg/kg/48 hrs
2mg/kg x 1,
then dose by levels
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Ideal Body Weight
Males

Females

Ht
(in)

Wt
(kg)

Ht
(in)

Wt
(kg)

60

50

60

46

61

52

61

48

62

55

62

50

63

51

63

52

64

59

64

55

65

62

65

51

66

64

66

59

61

66

61

62

68

68

68

64

69

71

69

66

10

13

70

69

If you have any questions regarding
appropriate dosing of extended-interval
aminoglycosides please contact the
pharmacy.
P.S.
If extended-interval ..dosing of
aminoglycosides is not appropriate for your
patient, a nomogram exists to assist you in
selecting therapeutic. doses. Please refer to
the following nomogram:
HULL & SARUBBI NOMOGRAM
FOR GENTAMICIN and TOBRAMYCIN DOSING
1. Select loading dose in mg/k9 (LEAN WEIGHT) to provide peak
serum level desired. Approximate peak levels from commonly
used loading doses are indicated below:
EXPECTED PEAK SERUM lEVEl lASED
UPON ONE·HOUR IV INFUSION

lOADING DOSE
2.0 mg/kg
1 7S mg/kg'
I S mglkg
1.2S mg/kg
1.0 mgikg

6·1 ug/ml
S·l ug/ml
4·6 ug/ml
3·S ug/ml
2·4 u9/ml

'IRecommencleG lot mosl moderalllo severe sysltiiiiC onlecloons.l

2. Select Maintenance Dose (as percentage of chosen loading dose)
to continue peak serum levels indicated above according to
patient's creatinine clearance and desired dosing intervals.

71

75

71

71

72

78

72

13

13

80

73

15

14

82

74

18

15

85

75

80

16

81

76

82

11

89

11

85

78

91

18

81

IS

19

94

79

89

80

96

80

92

'l

PERCENTAGE OF LOADING DOSE REQUIRED
FOR DOSAGE INTERVALS SELECTED:

Cr. Clur.

12 hrs.

24 hrs.

90
80
70
60

so

40
30
2S
20

~~

CrCI (males)

= (140-Age)

CrCI (males)

= (140-Age)

x (Weight)
SCr x 72

or

For dosing weight, actual body weight may
be used if patient is not obese. If patient is
obese ( > 20% ideal body weight), take 40%
of the excess weight and add to IBW i.e.
obese patient dosing weight = 0.4 x (actual
body weight - ideal body weight) + ideal
body weight.
In published data regarding extended-dosing
regimens for aminoglycosides, a greater
incidence of adverse effects have not been
demonstrated, specifically looking at otoand nephrotoxicity.

Scr
CrCI (female)

= 0.85 x either of above values

CrCI = creatinine clearance in mllmin
Scr = serum creatinine in mg/dl
Age is in years • Weight is in kg.
Hull & Sarubbi. AnNis at lntlfftil Mtdic1ne 85.183·189. 1976

PLEASE NOTE: For patients who have an
estimated CrCl < 50ml/min or whose age
2.. 70 years, a Q12 hours rather than Q8
hour dosing interval should be selected to
allow for the drug to be adequately cleared
and prevent accumulation.
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